This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Get started with wealth management for beginners in 2023. Learn the basics to build a solid financial foundation today!
18,336 articlesBiotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Serve Robotics beats Q4 revenue estimates, lifts 2026 guidance to roughly 10x 2025 levels, and gains credibility from...
A landmark Nvidia-backed investment could be a game changer for Nebius shareholders. This in-depth look breaks down w...
A wave of XRP buyers is pushing long bets higher across venues, but a troubling metric shows risk to a sustained rall...
U.S. drone output is under scrutiny as manufacturers push for scale. Red Cat and AeroVironment highlight a market shi...
MercadoLibre, the region’s tech and payments titan, has tumbled from its June peak but continues to post rapid revenu...
U.S. lawmakers pledge rigorous oversight as the DOJ expands its probe into Binance’s sanctions compliance. The move s...
As voice interfaces become a staple in shopping, SoundHound AI could rise as a key AI infrastructure layer. This arti...
Renowned investor Robert Kiyosaki warns that the market is entering a new phase of risk as liquidity drains from priv...
Walmart raises its payout to 0.99 per share, extending a 53-year dividend-raising streak and keeping Dividend King st...
Geopolitical tensions push on-chain activity higher, with stablecoin liquidity rising as crypto assets resist broader...
A look at how a $1,000 stake in McDonald’s versus Starbucks would have evolved over the past decade, with today’s mar...